Freeze-Drying of mRNA-LNPs Vaccines: A Review

Area of Science:

• Pharmaceutical Science
• Biotechnology
• Vaccine Technology

Background:

• Messenger RNA (mRNA) vaccines exhibit inherent instability, complicating storage, transportation, and equitable global distribution, especially in resource-limited settings.
• The limited shelf-life of current mRNA vaccine formulations poses a significant barrier to widespread accessibility.

Purpose of the Study:

• To review the current advancements in freeze-drying (lyophilization) techniques for stabilizing mRNA vaccines.
• To identify and discuss the challenges associated with freeze-drying mRNA vaccines.
• To provide insights into formulation components and process parameters for improved mRNA vaccine stability.

Main Methods:

• Literature review of freeze-drying techniques applied to mRNA vaccines.
• Analysis of factors influencing the stability of freeze-dried mRNA formulations.
• Overview of excipients, buffers, surfactants, process parameters, and storage conditions.

Main Results:

• Freeze-drying transforms mRNA vaccines into a stable dry powder, significantly enhancing long-term stability.
• Key factors influencing stability include formulation composition (excipients, buffers, surfactants) and process parameters.
• Optimized lyophilization protocols and storage conditions are crucial for maintaining vaccine efficacy.

Conclusions:

• Freeze-drying is a promising strategy to overcome the inherent instability of mRNA vaccines.
• Further research into robust and scalable lyophilization protocols is essential for improving global vaccine accessibility.
• Addressing stability limitations through advanced formulation and processing can enhance the reach of mRNA vaccine technology.